What You Should Know When Addressing GDMT For ID in Heart Failure

What You Should Know When Addressing GDMT For ID in Heart Failure is organized by Medtelligence.

Released: 09/30/2022
Valid until: 09/30/2023

Description:
Despite being an important and common comorbid condition in patients with heart failure, iron deficiency remains underdiagnosed and undertreated. Join Dr. Piotr Ponikowski, Dr. Andrew Sindone, and Dr. Adrian Hernandez as they discuss using guideline-directed medical therapy to overcome the morbidity, mortality, and very poor quality of life experienced by patients with heart failure and iron deficiency.

Learning Objectives:
After participating in this educational activity, participants should be better able to:
• Apply guideline recommendations for screening and diagnosis of iron deficiency in patients with heart failure
• Discuss the clinical impact of iron deficiency on patients with heart failure
• Evaluate the evidence-based treatment differences in clinical trial design with specific IV Iron products and their application in heart failure

Additional Details Will Be Posted as Soon as Information is Available.